Orthocell Statistics

Total Valuation

Orthocell has a market cap or net worth of AUD 306.28 million. The enterprise value is 286.36 million.

Market Cap	306.28M
Enterprise Value	286.36M

Important Dates

The next estimated earnings date is Friday, February 21, 2025.

Earnings Date	Feb 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Orthocell has 239.28 million shares outstanding. The number of shares has increased by 2.43% in one year.

Current Share Class	n/a
Shares Outstanding	239.28M
Shares Change (YoY)	+2.43%
Shares Change (QoQ)	+0.85%
Owned by Insiders (%)	20.63%
Owned by Institutions (%)	2.02%
Float	188.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	48.65
PB Ratio	59.11
P/TBV Ratio	87.85
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-39.88
EV / Sales	53.87
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-38.53

Financial Position

The company has a current ratio of 4.34, with a Debt / Equity ratio of 0.15.

Current Ratio	4.34
Quick Ratio	4.11
Debt / Equity	0.15
Debt / EBITDA	n/a
Debt / FCF	-0.09
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -134.46% and return on invested capital (ROIC) is -117.99%.

Return on Equity (ROE)	-134.46%
Return on Assets (ROA)	-25.04%
Return on Capital (ROIC)	-117.99%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.19
Inventory Turnover	1.47

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +220.00% in the last 52 weeks. The beta is 0.75, so Orthocell's price volatility has been lower than the market average.

Beta (5Y)	0.75
52-Week Price Change	+220.00%
50-Day Moving Average	1.16
200-Day Moving Average	0.63
Relative Strength Index (RSI)	55.70
Average Volume (20 Days)	2,011,826

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Orthocell had revenue of AUD 5.32 million and -7.18 million in losses. Loss per share was -0.04.

Revenue	5.32M
Gross Profit	3.69M
Operating Income	-11.26M
Pretax Income	-10.23M
Net Income	-7.18M
EBITDA	-10.91M
EBIT	-11.26M
Loss Per Share	-0.04

Full Income Statement

Balance Sheet

The company has 20.61 million in cash and 689,693 in debt, giving a net cash position of 19.92 million or 0.08 per share.

Cash & Cash Equivalents	20.61M
Total Debt	689,693
Net Cash	19.92M
Net Cash Per Share	0.08
Equity (Book Value)	4.53M
Book Value Per Share	0.02
Working Capital	17.70M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.51 million and capital expenditures -926,888, giving a free cash flow of -7.43 million.

Operating Cash Flow	-6.51M
Capital Expenditures	-926,888
Free Cash Flow	-7.43M
FCF Per Share	-0.03

Full Cash Flow Statement

Margins

Gross margin is 69.39%, with operating and profit margins of -211.92% and -135.10%.

Gross Margin	69.39%
Operating Margin	-211.92%
Pretax Margin	-192.51%
Profit Margin	-135.10%
EBITDA Margin	-205.25%
EBIT Margin	-211.92%
FCF Margin	n/a

Dividends & Yields

Orthocell does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.43%
Shareholder Yield	-2.43%
Earnings Yield	-2.81%
FCF Yield	-2.43%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Orthocell has an Altman Z-Score of -1.75. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.75
Piotroski F-Score	n/a